Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADI-PEG 20 in Advanced Melanoma
NCT00520299Phase 2Completed
- Sponsor
- Ludwig Cancer Research
- Start
- Jul 2007
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Pegargiminase in melanoma, sponsored by Ludwig Cancer Research. Started Jul 2007; status: completed.
02
Drugs
Pegargiminase
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00520299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520299.